Preview

User

Not a user? Register with this site Forgot your password?

Allergology and Immunology in Paediatrics

Advanced search

Editorial Policies

Aim and Scope

Allergology and Immunology in Pediatrics is the official journal of the Association of Pediatric Allergologists and Immunologists of Russia.  The journal has been published since 2003.

All position papers of the Association are published as journal articles and are available to specialists for free. The journal publishes original research and thematic review articles by Russian and international scientists. Special attention is given to the regional and geographic features of the occurrence and prevalence of allergic diseases among Russian children. Among the authors are key leaders from leading major regional universities in the Russian Federation.

Our goal is to provide open access to up-to-date scientific information and research results for practical pediatricians, allergists, immunologists, dermatologists, and research scientists. Since 2023, we have become bilingual, offering both Russian and English versions of our journal, which aligns with the principles of international scientific collaboration.

We provide doctors and scientists, including allergists, pediatricians, dermatologists, and immunologists, with the opportunity to engage in open scientific discussions and publish clinical cases and original articles. These articles focus on the study of the causes and treatment of allergic diseases, as well as the formation of the immune response in both normal and diseased conditions.

 

Section Policies

REVIEW
Checked Open Submissions Checked Indexed Checked Peer Reviewed
ORIGINAL ARTICLES
Checked Open Submissions Checked Indexed Checked Peer Reviewed
MEDICAL CASES
Checked Open Submissions Checked Indexed Checked Peer Reviewed
FROM THE EDITORS
Checked Open Submissions Checked Indexed Checked Peer Reviewed
COMMUNICATIONS AND CORRESPONDENCE
Checked Open Submissions Checked Indexed Checked Peer Reviewed
EDITORIAL
Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Publication Frequency

4 issues per year

 

Open Access Policy

This is an open access journal. All articles are made freely available to readers immediatly upon publication.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.

For more information please read BOAI statement.

 

 

Archiving

  • Russian State Library (RSL)
  • National Electronic-Information Consortium (NEICON)

 

Review policy

Adopted by the Editor-in-Chief: 30.07.2023

 

The editorial board of the journal “Allergology and Immunology in Pediatrics” adheres to COPE guidelines when working with manuscripts, reviewers and organizing peer review process.

Models of review

All manuscripts, submitted to the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” undergo a mandatory double blind review. It means neither the author nor the peer reviewer knows each other's names and places of work, and all correspondence is conducted through the Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”. Each manuscript is sent to at least two experts.

Review timeline

A peer review process in the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” takes an average of 1 to 6 months. In this timeline the editorial board of the journal includes time for the primary review of a manuscript, selection of reviewers, review preparation time, time for the article revision by the author and re-review, engagement of additional experts.

Review process

The decision of the choice of a reviewer for the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is made by the editor.

Each submitted article is reviewed by at least two experts. When getting different opinions about the manuscript, a third expert may be involved.

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” may send the author one of the following decisions:

Accept for publication. In this case, the manuscript will be included in one of the regular issues of the journal and transmitted to the editor for further work. The author will be notified of the publication date.

Accept for publication after correcting the shortcomings noted by the reviewer. In this case, the author will be proposed to make changes to the manuscript as specified by the reviewer within a week. When addressing shortcomings or giving motivated rejection to make changes, the manuscript is accepted for publication.

Accept for publication after correcting the shortcomings noted by the reviewer and re-review. In this case, the author will be proposed to make changes to the manuscript as specified by the reviewer within a week. The manuscript will be sent for re-review. The author will receive the final decision on the manuscript within 30 days.

Refusal to publish. In this case, the author will receive a motivated rejection to publish the manuscript. Refusal to publish does not prohibit further submission of manuscripts to the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”, however, if the publication is refused due to gross violation by the author, the chief editor may decide to blacklist the author. In this case, other articles of the author will not be considered.

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” provides three round of peer review — it means that after the first decision on article completion the author has two attempts to make changes, required by the reviewer or a motivated rejection to them. If after the third round of peer review the expert sends comments again, the editor of the journal will propose the author to consider publishing in another journal or re-submit the article with the changes after six months.

If the author does not plan to refine the article, he must inform the editorial board. The article will be discontinued.

If the author has a conflict of interest with the expert, who may potentially become the reviewer of the manuscript, he must inform the editor of the journal. The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” will select another reviewer, if needed.

In the process of reviewing the manuscript there might be a conflict between the reviewer and the author. In this case, the editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” has the right to appoint a new peer reviewer for the manuscript and involve the chief editor to resolve disputes.

The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” may publish articles of the Editor-in-Chief, their Deputy, executive secretary and members of the editorial board/staff, however, there must be no abuse of position. Manuscripts of the journal staff are sent for a double blind peer review only by external experts. Only external experts are involved to resolve contradictions and conflict situations. In case of the conflict regarding the fate of the chief editor’s manuscript, the final decision on the possibility of the article publication is made by the members of the editorial board/staff.

When publishing articles of the members of the editorial board/staff, Editor-in-Chief and their Deputy, information about authors’ affiliation to the journal is indicated in “Conflict of interest” section.

The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not exempt scientists’ manuscripts from peer review regardless of their status. 

Copies of review are stored in the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” for at least 5 years.

Reviewing staff

Peer review of all incoming manuscripts involves external experts with experience in the relevant subject area and publications on the subject of peer reviewed manuscript for the last 3 years.

In case the subject of the article is very narrow and/or the author declares a potential conflict of interest when peer reviewed by external experts, the members of the editorial board and/or staff may be involved in peer review.

Principles of peer reviewer selection and actions of the editorial board of the journal to ensure high quality expertise

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” carries out regular work on engaging recognized experts in the field of allergology and immunology, pediatrics and dermatology, to the work on the journal as well as on по the timely rotation of peer reviewers.

Peer reviewers are invited to work with the journal on the recommendations of the Editor-in-Chief, their Deputy, members of the editorial board/staff and also authors.

The executive editor of the journal regularly monitors publications on the subject of the journal in Scopus, Web of Science, RSCI databases and issues authors of publications an invitation for collaboration.

First peer review of new reviewers is assessed  by the following algorithm:

  1. Did the reviewer comment on the importance of the issue, raised in the study?
  2. Did the reviewer comment on the originality of manuscript?
  3. Did the reviewer identify strengths and weaknesses of the study (study design, data set and analysis)?
  4.  Did the reviewer make useful comments in regard to the language and structure of an article, table and drawings?
  5.  Were the reviewer’s comments constructive?
  6.  Did the reviewer present arguments, using examples from the article to substantiate their comments?
  7. Did the reviewer comment on the author’s interpretation of the results?
  8. Overall review quality.

Each point may be assigned on a scale of 1 to 5, where 1 — minimum score and 5 - maximum.

 

In case the quality of peer review does not satisfy the editor, cooperation with the reviewer stops.

The editors of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” have the right to evaluate unlimited number of reviews of all experts, engaged in working with the journal by the presented algorithm.

 

Mechanism of engaging peer reviewers in work with the journal

The editors of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” consider peer review one of essential procedures in work with the journal and value time and expertise of the experts, involved in peer review.

Reviewers of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” receive the right for priority publication as well as translation of the article text, accepted for publication, into English

Reviewers’ manes and places of work are published on the site of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” publicly available without specifying which articles they reviewed.

Confidentiality

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not transfer personal data of reviewers and authors.

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” treats any manuscript as a confidential document. The editorial board expects reviewers not to transfer manuscripts to third parties and discuss them without the consent of the editor.

Reviewers may involve third parties in work on peer review only with the consent of the editor.

Responsibility of the reviewer

By agreeing to peer review manuscripts for the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”, the reviewer agrees to follow the policy of the journal in assessing a manuscript, preparing peer review as well as regarding the reviewer’s behavior and compliance with ethical requirements.

The reviewer should be committed to providing the high quality of published materials in the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” as the editor does, and therefore should review a manuscript only if they have sufficient experience in this field and enough time for thorough and comprehensive verification of the article.

The reviewer is obliged to inform the editor of conflict of interest (of a personal, financial, intellectual, professional, political or religious nature) if there is any. In case of doubt, the situation should be discussed with the editor. 

The reviewer is obliged to refuse to review if he/she:

  • is the manager or subordinate of the author of the manuscript as well as the winner of joint grants;
  • does not plan to prepare peer review, but only wants to read the article;
  • is preparing own article on the similar subject for publication;
  • is reviewing an article on the similar subject.

The reviewer is obliged to inform the editor of their intention to review the article as well as to finish the work within the period specified by the editor. If peer review is impossible to carry out for a number of reasons, it is appropriate to recommend the editor another expert.

The reviewer cannot use their position for personal purposes and impose authors references to their works.

All materials, received from the editor of the journal, are strictly confidential. The reviewer must not transfer materials to third parties and involve other experts in the manuscript review without consent of the editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.

Recommendations to reviewers

For the convenience of reviewers, the editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” offers the form for rapid peer review – it reflects the questions, answers to which are needed for the editor to make a decision on the article.

The editorial board of the journal asks the reviewer to pay special attention to the “Comments” section to help authors improve current and future work.

Review content and structure

NEICON recommendations are used to create the section. The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” got NEICON permission to use the guidelines in the review policy.

10 criteria by which the manuscript should be evaluated:

  •   originality; 
  •   logical rigor;
  •   statistical rigor; 
  •   clarity and brevity of writing style;
  •   theoretical importance; 
  •   reliable results; 
  •   relevance for modern research areas; 
  •   reproducibility of results; 
  •   scope of the literature; 
  •   application of the results. 

In addition to the form for rapid peer review the editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” recommends reviewers to adhere to the following review structure.

Comments for editor

Conflict of interest — it describes a real or potential conflict of interest related to the content of the manuscript or its authors that may lead to the biased conclusion. 

Confidential comments — this section is intended for comments that will not be transferred to authors. It includes the reviewer’s final conclusion on the fate of the submitted manuscript, their assumption, expression of doubt with regard to possible breach of ethics, and also recommendations and accompanying commentary (e.g., the reviewer may advise the editor to request additional information from the author). The assumed solution — as a rule, a brief conclusion on the fate of the manuscript (accept for publication, accept for publication after minor revision, accept for publication after considerable revision, reject, reject and propose the author to resubmit the article). 

Comments for authors

Introduction — the section describes the main conclusions and value of the article for readers. General comments — this section describes relevance for the goals and objectives of the journal, credibility and ethical behaviour. 

Special comments — the reviewer evaluates the sections of the article (abstract, introduction, methods, results, discussion) or comments on particular pages, paragraphs or lines. 

Recommendations to the author — the reviewer gives the author recommendations to enhance the quality of the manuscript or, perhaps, future studies. 

Final comment — a brief description of strong and weak points of the manuscript without any additional recommendations.

Manuscript evaluation criteria

Compliance with the subject area

 Time should not be spent on reviewing an irrelevant manuscript, regardless of its quality. It is first necessary to determine if the manuscript corresponds to the subject area of the scientific journal and interests of its audience. 

Significance

 Does the work meet all the necessary requirements in study design, scientific methods, structure and content as well as depth of analysis, does not it derogate from the principle of impartial scientific research? Are study results reproducible? Is the study sample properly selected? Is it analysed in detail to generalize the findings of the study?

Novelty

Has the research brought something new to the relevant subject area? 

Ethics

 Does the research meet the requirements of originality, is it approved by the expert board (if it is provided), is it impartial as regards conflict of interest? No matter how high perceived significance of the manuscript is, it cannot me admitted to publication in the case of redundancy, plagiarism or breach of basic ethical principles of scientific research: legitimacy, benefit and respect for people.

Evaluation of manuscript elements

The editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” proposes the following questions to expedite the preparation of the expert opinion and to provide the editor and author the most comprehensive information on the article.

Title  

Does the title correspond to the content of the manuscript? Will the title draw reader's attention? 

Abstract

 The abstract should properly present the content of the manuscript (abstract is structured, description of the objectives, methods, results and significance are presented)?

Is there any discrepancy between the abstract and sections of the manuscript? Is it possible to understand the abstract without reading the manuscript?

Introduction

Is the introduction brief? Is the objective of the study clearly defined and the task set? Does the author substantiate the relevance and significance of the study, based on literature review? If yes, dies this part meet the volume requirements? Does the author give definitions of the terms, met in the manuscript? If the manuscript is directed to the “Original research” section, is there any clearly articulated hypothesis in it?

Literature review

How holistic is the literature review? 

Methods

Can another researcher reproduce study results, using the proposed methods or the methods are not clear? 

Do authors justify their choice when describing research methods (e.g., the choice of imaging techniques, analytical tools or statistical methods)? 

If authors hypothesize, have they developed methods that allow to have a justified test of that hypothesis? 

How is the research design presented? 

How data analysis helps in achieving the objective? 

Results  

Are results clearly explained? Does the procedure for submitting results coincide with the one for describing methods? Are results justified and expected or unexpected? Are there any results, which are not preceded by the relevant description in the “Methods” section? How accurate is presentation of results? 

Discussion

Is the discussion brief? If no, how to shorten it?

 If hypothesis is proposed, do the authors report that it has been confirmed or refuted? If the hypothesis has been refuted, do the authors report there is the answer to the question raised in the study? Are the authors’ findings consistent with the results, obtained in the study? If unexpected results are obtained, do the authors properly analyse them? What potential contribution does the study make to the field and global science?

 Conclusions

Do authors note study limitations? Are there any additional limitations that should be noted? What is the author’s opinion on these limitations? What is the author’s view on the direction for the future research? 

List of references

Does the list of references correspond to the format of the journal? Are there any bibliographic mistakes in the list of references? Are references to the manuscript from the list correct in the text of the manuscript? Are there any important works that have not been mentioned, but should be? Are the references in the manuscript more than necessary? Are the cited references relevant? 

Tables

 If there are any tables in the manuscript, do they properly describe the findings? Should one or several tables be added to the manuscript? Are the data, presented in the tables, processed accordingly and does it facilitate the perception of information and does not complicate it?

 Figures

 Are tables and figures a suitable choice for solving the objective? May the results be illustrated in a different way? Are figures and charts accurate in showing important results? Are any changes in figures and charts necessary for a more accurate and visual presentation of the results? Do figure and chart captions make it possible to understand information without reference to the manuscript itself?

 Disclosure of conflict of interest 

Is the information about financing and conflict of interest clearly indicated?

Reviewer’s final decision

The editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” proposes the following rational for the reviewer’s final decision.

Accept for publication

The reviewer understands that the manuscript is ready for publication in the current view. The manuscript is substantiated, ethical and significant for the scientific community and complements already published works, the writing style is clear and concise. 

Accept after minor revision

There are minor remarks relating to the manuscript that need to be corrected. It might be a bad style of the manuscript, lack of clarity, poor structure, mistakes in the references, duplication of information in figures, tables and texts of the manuscript. After revision and reassessment, the manuscript may be accepted for publication. 

Accept after considerable revision and peer review

 The manuscript has serious shortcomings and mistakes, affecting the reliability of the results obtained: problems with ethics, study design, gaps in the description of research methods, poor reporting or misinterpretation of results, not sufficient information about constraints of the research being undertaken, conflicting (or refuted by the author’s own statements) conclusions, lack of references to important studies, unclear tables and figures, requiring serious revision. After reassessment the manuscript may be accepted, rejected or sent for additional examination. Such decision often requires additional data collection from the author. 

Reject  

The work does not correspond to the aims and objectives of the journal, has one or several unsolvable shortcomings or serious ethical issues: consent to the publication has not been obtained in cases when it is necessary, research methods are unethical, methodology is discredited or flawed (e.g., the process, seriously affecting results is ignored). With such decision the author should not submit the corrected manuscript without a special request. The reviewer should give detailed comments, arguing their decision, as they may help the author significantly improve the work.

 Reject and invite the author to resubmit the manuscript

The theme and the question risen in the study seem to be interesting, but the author uses incorrect or insufficiently reliable methods, consequently, data obtained is also not reliable. Such decision is also possible in cases when a manuscript requires many changes or when requested additional information cannot be obtained from the author. Authors are proposed to conduct research in view of recommended changes again and submit new results for consideration.

Review editing

The editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” expects that reviews will be written in respectful terms and in accordance with the rules of the Russian language. Ad hominem attack, author abuse and irrelevant criticism of any aspect of the study, language and style of the manuscript are prohibited.

The editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” tries to send reviews to authors in its original form, however, in some cases it may be necessary to change the review text without losing its meaning (e.g., when combining comments of several experts on one issue or if there is confidential information in the review section which is intended for the author).

The editorial board of journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” has the right to submit a review for revision to the expert in case of numerous mistakes or unacceptable tone of the review.

 

Publishing Ethics

Policy adopted by Editor-in-Chief: 30.07.2023

Authorship, contribution of authors, acknowledgements

Authorship

Journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” adheres the following criteria for authorship (developed and described in ICMJE recommendations):

  1. significant contribution to concept development or planning of scientific work, or obtaining, analysis and interpretation of the work; and 
  2. drafting or critical revision of the manuscript with a valuable intellectual content; and 
  3. final approval of the published manuscript version; and 
  4. consent to be responsible for all aspects of the work and ensure that all issues, related to the accuracy and integrity of all parts of the work can be appropriately investigated and resolved.

In addition to being accountable for the parts of the work an author has done, he (she) should be aware which specific parts of the work other co-authors are responsible for.

Furthermore, authors should be assured of the good faith contribution of their co-authors. All persons designated as authors should meet all the given four criteria, applicable to the author, and all those who meet the four criteria should be identified as authors.

Persons who do not meet all the four criteria should be mentioned in the “Acknowledgements” section.

Contribution by authors and people other than authors

People, who have put a considerable contribution to the work, but do not respond the authorship criteria can be mentioned in “Acknowledgements” section, for example: supporting the study, acting as a mentor, assisting with data collection, coordinating the study, etc.

To correctly define contribution, authors of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” can use one of the models recommended by COPE:

 

Responsibility

Responsibility for compliance with standards of authorship and author contribution remains with the editors of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.

Authors are obliged to provide transparent and correct information about the authors of the article and persons who have made a significant contribution to its preparation.

 

In case the manuscript is under consideration in the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” by the Editor-in-Chief, Deputy Editor-in-Chief, a member of the editorial board, the manuscript will be reviewed only by an external expert.

 

To correctly define contribution for the article preparation, the following resources should be used:

Authorship statement

 Editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” requires authors to submit an authorship statement together with the manuscript, signed by all the co-authors.

By signing the statement, authors guarantee:

  • each author, who signed the statement, meets the authorship criteria, set out in the Ethical Policy of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”;
  • all the persons, involved in the study but not being the authors, are mentioned in the “Acknowledgements” section;
  • description of each author’s contribution, this information will be published in the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”;
  • the authors take responsibility for the correctness of the information provided.

 

At submission the editor checks for information about the authors and all necessary documents. In the absence of the authorship statement or all the authors' signatures the article is not accepted for consideration.

Disputes

If any disputes concerning the authorship arise, the article review is terminated regardless of its stage (consideration, reviewing, editing or preparing for publication).

All co-authors are informed of the dispute concerning the authorship via e-mail.

The Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” has the right to specify the exact period, during which the authors may provide clarification on the mentioned issue. After this period, the article should be withdrawn from publication with an explanatory note. In case the article was published in Online First, explanatory notes on the removal of the article from publication are publicly available.

In case the dispute arose over the published article, the Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” publishes a correction, refutation or retracts the article with the reasons for the changes to the published document.

 

If there is the need to add or delete a co-author before and after publication, the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” acts in accordance with the COPE rules:

 

To prevent manipulation with co-authoring, the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” uses COPE flowcharts and when working with articles it draws attention to the following:

  • Stated that the study was funded by organizations, which authors are missing in the general list. It requires a thorough review of all the authors’ contribution and, if necessary, request for clarification from the responsible author.
  • The list includes authors from other scientific fields. This may indicate gift authorship.
  • Mention of a person in the “Acknowledgements” section without specifying the particular contribution.
  • Very long or very short list of authors, unusual for the given scientific field or type of article.
  • Incomplete description of the authors’ contribution: e.g., no information indicating the person who prepared the draft version of the manuscript or processed data.
  • Checking with the help of Anti-Plagiarism shows borrowing from the dissertation work which author is not mentioned in the list of authors.
  • Articles devoted to similar topics were published by other groups of authors.
  • The list of authors is suddenly changed at the publication stage without first discussing it with the editorial board of the journal.
  • The author has a lot of publicity, though their position does not imply such publication activity (Head of the Department, Director of the Institute).
  • The author, responsible for correspondence, cannot respond reviewers’ comments.

 

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” expects that organizations affiliated with the author will be ready to participate in the investigation of disputes concerning the authorship.

Complaints and appeals

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is attentive to all complaints about the behaviour of editors and reviewers, that might deal with issues such as breach of confidentiality, undisclosed conflict of interest, misuse of confidential information, obtained in the course of reviewing. Authors may also dispute decisions concerning expressed doubt on certain articles or complain about the violation of editorial processes.

All complaints can be sent to the e-mail address editor@elpub.ru и adair@adair.ru, they will be considered according to the general procedure. The complaint process does not take more than 7 days. The complainant is informed of the decision as well as measures to be taken and a timeframe for their implementation.

In dealing with complaints, the editorial board relies on COPE guidelines in each of the following cases:

  • work with post-publication criticism
  • post-publication discussions and amendments
  • suspicion of manipulation with peer review after publication
  • manipulation of images in the published article
  • data fabrication in the published article

Conflict of interest

Section prepared on WAME guidelines

Conflict of interest is situations causing conflicting or competing interests that may affect the Editor’s decisions as well as data interpretation in the article. Conflicts of interest may be potential or recognized, and also actually existing. Personal, political, financial, scientific or religious factors can influence the objectivity.

Conflicts of interest may cover the following areas:

  • Financial: this conflict arises when the participant in the publication process has received or expects to receive money (or other financial benefits, such as patents and shares), gifts or services that might affect the work, related to a specific publication. Examples: fees for the research, consulting, public performances, etc.
  • Personal relationships: this conflict arises in case of personal relations with family, friends, competitors, former colleagues.
  • Political and religious beliefs: commitment to one religion, political party may influence on results of the article consideration which examines these issues.
  • Institutional affiliation: this conflict arises when a participant of the publication process is directly related to the institution, interested in publishing.

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” can ask authors additional questions or request additional information if necessary.

Conflict of interest may concern authors, peer reviewers and editors. The following policy provision have been prepared based on ICMJE guidelines.

Responsibilities of authors in disclosing a conflict of interest

When authors submit any type or format of manuscripts, they are responsible for disclosing all relationships and activity that might bias or be considered to bias their work.

The author is obliged to inform the editor of any actual or potential conflict of interest by including information about conflict of interest in the relevant section of the article.

If the author has no conflict of interest to declare, they must also state this in the manuscript. For example: “The author declares no conflict of interest”.

Responsibilities of peer reviewers in disclosing a conflict of interest

Peer reviewers must inform editors of any conflict of interest that may affect their opinion about the manuscript, and they must abandon the review on the grounds of any bias. Peer reviewers should not use information about the reviewed work to their advantage before it is published.

Responsibilities of editors in disclosing a conflict of interest

Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have a conflict of interest or relationships that may pose potential conflicts related to articles under consideration. Other members of the editorial board who participate in decision-making must inform editors of their current interest (as they may affect decisions of the editorial board) and independently refuse to make decisions in the presence of a conflict of interest. The editorial members must not use the information obtained when working with manuscripts for personal purposes. Editors should regular publish reports about potential conflict of interest, associated with their activity and the ones of the journal staff. Guest editors should follow the same procedures. 

Articles by the Editor-in-Chief, Deputy Editor-in-Chief, members of the editorial board and editorial council of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” should clearly indicate the link to the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.

 

If undisclosed conflict of interest is found in an unpublished article, the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” acts in accordance with COPE guidelines.

If undisclosed conflict of interest is found in a published article, the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” acts in accordance with COPE guidelines.

Reuse and reproduction of data

This section of policy is based on COPE guideline regarding work with data.

Authors are encouraged to provide access to the data obtained during the course of the study and justifying the content of their publication, but it is not required. Authors consent to access research data does not affect the decision on publication.

Determination of research data

Research data includes any actual materials recorded on any medium and used in the process of obtaining the study results, both digital and on-digital. These include tabular data, code, images, audio and video files, documents, maps, processed and/or raw data. This policy applies to research data that may be needed to confirm the reliability of the research results, set out in articles published by the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”. Research data include information obtained directly by authors (“primary data”), as well as other open-source data, analyzed by the authors in the course of the study (“secondary data”). 

Definition of exceptions

This policy does not apply to research data, not required to verify the validity of the results stated in published articles.

Information that is not subject to disclosure may be reported as follows: placed in research data repositories with restricted access; preliminary anonymized. The author can make only research data metadata publicly available and/or describe how they can be accessed upon the request of other scientists as well.

Data storage

The preferred way of exchanging data is to use data repositories. If you need help choosing a repository to host your data, refer to the list of repositories on the site: https://repositoryfinder.datacite.org/.

Citation data

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” welcomes easy access to research data under a free license Creative Commons. The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not insist on mandatory free software licenses usage if placed on third-party repositories. The Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not claim ownership rights over the research data, provided by the author together with the article.

A letter on the matter of compliance with the policy can be sent to the responsible secretary of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.

Ethical oversight

The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” shares the view with COPE that publication ethics include not only ensuring the integrity of the published research, but also ethical behavior towards research subjects. Vulnerable groups, laboratory animals, people (if relevant studies are carried out), confidential data and business/marketing practices fall into this category.

Informed consent/consent for publication

The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” requires informed consent/consent for publication to be submitted for any study, where a person or a group of persons may be identified. This form of consent is also necessary when the study mentions dead people. Consent is required when publishing a clinical case, photographs, X-ray, etc.

Authors should provide the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” with the statement where informed consent is given by the patient or their representative. The published article will contain information on such consent.

 

Information provided with the informed consent:

  1. Patient’s name and signature.
  2. If the patient cannot sign the consent themselves, it is necessary to specify who signs the consent and their relationship to the patient.
  3. If an individual signs the consent on behalf of a family or group, they must confirm that all family members or members of the group have been informed.
  4. It should be specified that the individual or a group of persons has no legal, mental or physical obstacles to give consent to the publication. If such reasons exist, they must be stated (minor children, low intellectual capacity, disability, death).
  5. An individual, obtaining informed consent, must have the authority for this act.
  6. It should be specified that even with the observance of all the rules anonymity cannot be guaranteed.
  7. It should be specified that the patient can withdraw the consent at any time, but not after publishing the article.
  8. The form shall indicate how the article will be distributed (in print, online).
  9. The form must state that the patient has seen the final version of the manuscript. If not, it must be specified that the patient or trustee has consented to the publication without reading the final version of the article.

Vulnerable groups

Vulnerable groups include (but are not limited to) those who are unable to protect their interests: pregnant women, newborns, children, fetuses in the womb, prisoners, people with disabilities, intellectual health (development) delay (disorder), economically disadvantaged, hospitalized patients in serious condition, etc.

Research in vulnerable groups should be planned only if these groups will benefit from it.

One of concerns is that not all study participants, for objective reasons, can understand all conditions for scientific research. If informed consent cannot be obtained from the direct study participant, this consent must be signed by their legal representative. Research involving children should be given special attention.

 

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” supports COPE statement on the study publication, concerning vulnerable groups.

 

The authors of the articles must obtain informed consent to the publication and inform the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.

Ethical conduct of research using animals

While conducting experimental research on animals, the authors are obliged to indicate compliance with institutional and national standards for using laboratory animals.

To ensure the accuracy of information on animal studies the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” recommends using  ARRIVE standards. The use of these standards will both improve the quality and reliability of published articles and allow other researches to reproduce the results.

Research involving humans

The journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”  adheres the principles of the World Medical Association Declaration of Helsinki (WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects) and seeks to ensure compliance with ethical standards of research data collection, which is done in people. Before starting research, the scientist must get acquainted with the provisions on informed consent to the Declaration of Helsinki and conduct the study rigidly in accordance with the principles set out below (the provisions of the Helsinki Declaration were quoted 25-32). When presenting the results of experimental study in humans, the authors must indicate whether the procedures were consistent with the ethical standards in the Declaration of Helsinki. If the study was conducted without regard to the principles of the Declaration, the authors should justify the chosen approach to the research and guarantee that the institution’s ethics committee, where the study was conducted, had approved the chosen approach.

«25. Participation by individuals capable of giving informed consent as subjects in medical research must be voluntary. Although it may be appropriate to consult family members or community leaders, no individual capable of giving informed consent may be enrolled in a research study unless he or she freely agreed.

  1. In medical research involving human subjects capable of giving informed consent, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflict of interest, institutional affiliation, the anticipated benefits and potential risks and the discomfort it may entail from participation in the study, post-study provision and any other relevant aspects of the study. The potential subject must be informed of the right to refuse to participate in the study or to withdraw consent to participate at any time without reprisal. Special attention should be given to the specific information needs of individual potential subjects as well as to the methods used to deliver the information.

After ensuring that the potential subject has understood the information provided to him, the physician or another appropriately qualified individual must then seek the potential subject’s freely-given informed consent to participate in the study, preferably in writing. If the consent cannot be expressed in writing, the non-written consent must be formally documented and witnessed.

All medical research subjects should be given the option of being informed about the general outcome and results of the study.

  1. When seeking informed consent for participation in the study, the physician must be particularly cautious if the potential subject is in a dependent relationship with the physician or may consent under duress. In such situations, informed consent should be sought by an appropriately qualified individual who is completely independent of this relationship.
  2. For a potential research subject who is incapable of giving consent, the physician must seek informed consent from the legally authorized representative. These individuals must not be included in a research study that has no likelihood of benefit for them, unless it is intended to promote the health of the group represented by the potential subject, the research cannot instead be performed with persons capable of providing informed consent, and the research entails only minimal risk and minimal burden.
  3. When a potential research subject who is deemed incapable of giving informed consent is able to give assent to decisions about participation in research, the physician must seek that assent in addition to the consent of the legally authorized representative. The potential subject’s dissent should be respected.
  4. Research involving subjects who are physically and mentally incapable of giving consent, for example, unconscious patients, may be done only if the physical or mental condition that prevents giving informed consent is a necessary characteristics of the research group. In such circumstances the physician must seek informed consent from the legally authorized representative. If no such representative is available and if the research cannot be delayed, the study may proceed without informed consent provided that the specific reasons for involving subjects with the condition that renders them unable to give informed consent have been stated in the research protocol and the study has been approved by a research ethics committee. Consent to remain in the research must be obtained as soon as possible from the subject or a legally authorized representative.
  5. The physician must fully inform the patient which aspects of their care are related to the research. The refusal of a patient to participate in the study or the patient’s decision to withdraw from the study must never adversely affect the patient-physician relationship.
  6. For medical research using identifiable human material or data, such as research on material or data contained in biobanks or similar repositories, physicians must seek informed consent for its collection, storage and/or reuse. There may be exceptional situations where consent would be impossible or impracticable to obtain for such research. In such situations the research may be done only after consideration and approval of a research ethics committee.

Confidential data management

Right to privacy of any person or organization involved in the study is of paramount importance and must not be infringed without consent. The authors must take all necessary precautions to protect information about the participants in the study. If needed, the authors must take measures to minimize any potential physical and psychological harm to the participants in the study.

Post-publication discussions and changes to published articles

In some cases, it becomes necessary to introduce changes in an already published article. The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” endorses the practice of changing published material and acts in accordance with  COPE guidelines in case of need.

 

Any necessary changes are notified after publication, which will always be related to the original version of the article so that readers can be informed of all necessary changes. The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” uses Expressions of concern, correction or retraction. The purpose of this practice is to ensure the integrity of scientific materials.

All corrections, expressions of concern and retractions are publicly available.

What authors should do if any error in their article is discovered?

Authors may discover technical or semantic errors after the publication of the article. In this case authors should inform the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” as soon as possible, especially in cases when errors may influence the interpretation of the results or cause doubts about the reliability of the information. The author, responsible for correspondence, bears responsibility in the group of authors to reach agreement on further cooperation with the editorial board.

If you believe that a published article should be changed, contact us by email adair@adair.ru

Algorithm for making changes in the article

Correction

An article is corrected if it is necessary to correct an error or bring the missing information, and it doesn’t affect the integrity and scientific significance of the article.

Corrections may be made, for example, to a caption, information on research funding may be added or information on conflict of interest may be clarified.

If such changes are made, a separate statement regarding the correction is published. The general algorithm of actions is as follow:

  • corrections are made in the original version of the article;
  • Crossmark record is updated;
  • the description of the changes made is entered in the “Abstract” box of the article original version;
  • a statement regarding the correction with the information on the original version of the article as well as links to it, the author’s names and the description of the correction essence is published.

Statements regarding the correction of spelling, typographical errors, minor changes are not published independently. The site reports that the article has been corrected (without detailing).

Retraction

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” makes a decision on the need for article withdrawal in the following cases:

  • when there is a clear evidence that the results are unreliable for a number of reasons: there are serious errors in calculations, fabricated data, manipulation of images;
  • plagiarism is detected in the article;
  • results have already been published in other journals, and the author has failed to justify the need of re-publication and to inform the editor about it;
  • the article contains materials and data which have not been authorized;
  • there is copyright violation or another serious legal issue has arisen (e.g., breach of confidentiality);
  • violation of research ethics;
  • the peer review process has been compromised;
  • the author did not disclose conflict of interest, which, in the editor’s opinion, could affect the decision of the peer reviewer or the editor on the publication of the article.

 

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” acts according to the following algorithm in case of retracting articles:

  • carry out an investigation and make sure the retraction is necessary;
  • make a statement on the retraction: include the mark “Retraction” и the title of the article, describe the retraction cause, mention who has initiated it, provide the link to the retracted article;
  • publish the statement on the retraction;
  • change the original version of the retracted article, noting in the pdf that the article is retracted;
  • the statement on the retraction in databases;
  • convey information about the retracted article to the database of retracted articles.

 

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” works with retracted articles according to COPE regulations.

 

Expression of doubt

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” expresses doubts in the following cases:

  • There were serious concerns about the published article, but investigation failed to prove anything or, for some reasons, the investigation will not be conducted or или cannot be completed for a long time. In this case, readers must be immediately informed about it.

After the investigation is completed, the article may be changed or it may be retracted.

Article removal

Articles are removed from the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” only in extreme cases, when it is impossible to follow the change protocol, retraction or expression of doubt.

An article can be removed in the following cases:

  • is distribution of the article may pose a serious risk;
  • if the article contains any content that violates the right to privacy of a research participant;
  • if the article violates rights;
  • if the article is subject to removal by a court decision.

In case an article is removed, all the materials are deleted from the journal site, requests to remove the full text and to post a statement on the article removal are sent to databases.

Update and post-publication of articles

Supplement to the published article

An author may need to supplement the article some time after its publication. In this case, the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” can publish a supplement to the article. It must be reviewed by the editors of the journal and may be directed for peer-reviewing.

When publishing supplements, the file with the original version of the article is updated, and a statement on the article supplement, including information about the article, its authors, the essence of the changes made and the link to the article is added to the current issue of the journal.

Commentary on the published article

Commentaries constitute short materials that may express an opinion or observation on the published article. Comments are conveyed to the peer reviewers and the authors of the article to give opportunity to prepare responses.

Commentary by the author is also sent to the peer reviewer. The author of the comment will have the opportunity to answer the author once again, after that the correspondence between the author of the comment and the author of the article may continue privately.

The decision on the commentary publication is made by the Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”. Comments, responses and replies are linked to the original version of the article to which they relate.

Responsibility of the Journal Management: editorial board, editors, publisher, founder

Principles for the formation of the editorial board

The editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” follows COPE guidelines when forming the editorial board/staff.

 

Actual members of the editorial board, peer reviewers and authors can recommend potential members of the editorial board/staff to the chief editor.

Editors, who wish to take part in the journal work as members of the editorial board/staff can send an application to the chief editor.

 

All potential members of the editorial board/staff must agree to the following conditions:

  • a member of the editorial board/staff of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” cannot be an editor, holding the same position in more than one another journal;
  • a member of the editorial board/staff of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” cannot be an editor, concurrently invited to work with the special issue of another journal;
  • a member of the editorial board/staff of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” cannot be an editor who is concurrently the Editor-in-Chief of another journal;
  • a member of the editorial board/staff of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” cannot be an editor, concurrently responsible for making final decisions on the publication of manuscripts in another journal;
  • all potential members of the editorial board/staff must be prepared to provide the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” information about all potential and actual conflict of interest (e.g., any activities related to the publication of scientific journals and books, membership in the editorial board/staff of other journals as well as any conflict of interest that may arise after their appointment).

 

Duties of the editorial board/staff member:

  • Publication of 1 article per year to support the journal;
  • Peer review of incoming manuscripts on their profile and in the absence of external reviewers. For peer review each member of the editorial board/staff obtains no more than 2 manuscripts per year. Peer review must be carried out in accordance with the approved peer review policy of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”.
  • The selection of reviewers for incoming articles at the request of the responsible secretary, control of the peer review process of incoming articles.
  • Making a decision on the possibility of publishing an article after all rounds of peer review. Decisions are passed to the chief editor who makes the final decision on the possibility of the publication.
  • Invitation of authors and reviewers to cooperate with the journal.

The member of the editorial board/staff may be dismissed for the following reasons:

  • Violation of the publication ethics: concealing conflict of interest, information, using the status for personal advantage;
  • Failure to perform the duties assigned for a year without good reason and consent of the Editor-in-Chief;
  • On request of the member of the editorial board/staff.

 

Privileges of the member of the editorial board/staff

  • articles of the members of the editorial board/staff in the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” are considered in priority order;
  • 1 article per year is translated into English on account of the editorial board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”;
  • members of the editorial board/staff of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” are exempt from payment for editorial services;
  • the member of the editorial board/staff may participate in events, held by the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” and an initiating body for free;
  • the member of the editorial board/staff may act as a guest editor in the special issue of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS”;
  • information on the member of the editorial board/staff is placed on the site of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” with necessary links to the profile in databases, affiliations and other related data.

 

The possibility of participating potential candidates as a member of the editorial board/staff is considered on regular meetings of the editorial board/staff.

The final decision on including a potential candidate in the editorial board/staff is made by the Editor-in-Chief.

Duties of the Editor

The editor of the scientific journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is personally and independently responsible for making a decision on the article publication. The final decision on the publication is made by the Editor-in-Chief of the journal.

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is guided by the journal policy in considering an article and making a decision on its publication.

The editor may discuss the article and the reviewer’s comments with other editors and peer reviewers provided the discussions are justified and legitimate without using the materials under discussion for personal purposes.

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” must assess the contents of the manuscript regardless of authors’ race, sex, sexual orientation, religious beliefs, origin, nationality or political preferences.

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is obliged to monitor the confidentiality and not to disclose, without necessity, information about the manuscript to third parties (except for the other editors of the journal, peer reviewers, editors and founder).

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” must inform the Editor-in-Chief about all conflict situations as well as discovery of critical mistakes or author’s or reviewer’s allegations of violating publication ethics, received by the journal, in order to undertake necessary actions: changes, publishing refutations, retraction, expressions of concern.

The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” takes part in the investigation of any ethic violations, concerning manuscripts under consideration and published articles, and makes every effort to resolve conflicts. If needed, the editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” cooperates with the author’s organization for a more in-depth investigation. 

 

Duties of the Publisher

The editor board of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” is responsible for compliance with all current recommendations and guidelines on promoting integrity of scientific materials, published in the journal.

The Editor follows the policy of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” regarding compensation for the preparation and publication of manuscripts as well as profiting from print advertising and reprints. The editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not allow potential profit from advertising and reprints to affect the editors’ decision-making on publishing a manuscript.

The Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not meddle into editorial processes, however, if necessary and upon request of the editors may participate in the investigation of violating the publication ethics as well as make official inquiries on their behalf to scientific and educational organizations along with other publishers.

The Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” must promote the industry standards in the publisher work to improve the ethical content of the journal.

The Editor of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” must provide comprehensive legal support to the editorial board of the journal if needed.

 

Duties of the Founder

The Founder of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” adheres to the principle of editorial independence: the director of the founding organization and its staff do not meddle into the editorial process.

The Founder of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” may recommend potential members of the editorial board/staff, peer reviewers and authors, however, the final decision on the possibility of cooperation with them is taken only by the Editor-in-Chief.

The Founder of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” supports the need to provide geographical and gender diversity among the members of the editorial board/staff, peer reviewers and authors.

The Founder of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not put financial and political gains ahead of the quality of the journal. The editors of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” make a decision on the publication of manuscripts, based on their quality and interest to the targeted audience of the journal.

The Founder of the journal “ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS” does not meddle into editorial processes, however, if necessary and upon request of the editors may participate in the investigation of violating the publication ethics as well as make official inquiries on their behalf to scientific and educational organizations along with other publishers.

 

Author fees

The journal is free for authors. It is financially supported by the Association of Pediatric Allergologists and Immunologists of Russia. A fee is charged for reprints and advertising modules.

 

Disclosure and Conflict of Interest

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

Plagiarism detection

"Allergology and Immunology in Paediatrics" use native russian-language plagiarism detection software Antiplagiat to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.

 

Preprint and postprint Policy

The editorial board of the «Allergology and Immunology in Pediatrics» allows authors to post the manuscript as a preprint before submission for review and to archive independently their articles in disciplinary and institutional repositories.

 

Preprints

The editorial board of the «Allergology and Immunology in Pediatrics» encourages uploading preprints on preprint servers. The Committee on Publication Ethics (COPE) defines a preprint as 'a scholarly manuscript posted by the author(s) in an openly accessible platform, usually before or in parallel with the peer review process.' 

A preprint publication shall not be considered duplicate publication nor shall it influence the editor's decision to publish it in the «Allergology and Immunology in Pediatrics».

The author must notify the editorial board of the «Allergology and Immunology in Pediatrics» about the posted preprint at submission of the manuscript for review, furnishing a link to the preprint with its DOI identifier and the dissemination terms and conditions.

It is the author’s responsibility to add a link to the published manuscript in the preprint record. The link must contain the DOI and the URL of the article published on the journal's website. The original preprint should not be modified based on the reviewer’s and editor’s comments. The preprint should not be replaced with the text of the published article.

Do not delete the preprint text.

 

Manuscripts Accepted for Publication

The editorial board of the «Allergology and Immunology in Pediatrics» allows manuscripts that have been reviewed and are accepted for publication to be archived independently.

 This version of the manuscript may be disseminated through:

-  personal website or blog;

-  institutional repository;

-  disciplinary repository;

-  direct interactions with faculty or students by providing this version of the manuscript for personal use.

 

The text of the manuscript should contain the author’s clarifications about its status and information about the planned publication.

 

Example: The ARTICLE TITLE has been reviewed, accepted for publication, and will be published in 2021 (3) of the «Allergology and Immunology in Pediatrics».

 

Once the final version of the manuscript is published, it is the author’s responsibility to add a link to the published article to the publication record. The posted text should not be modified based on the reviewer’s and editor’s comments. Do not replace the text of the posted manuscript. Do not delete the text of the posted manuscript.

 

Final Versions of Manuscripts

The editorial board of the «Allergology and Immunology in Pediatrics» allows manuscripts that have been peer-reviewed, accepted for publication, edited and ready for publication (proofread and typeset) to be archived independently.

 This version of the manuscript may be disseminated through:

-  personal website or blog;

-  institutional repository;

-  disciplinary repository;

-  direct interactions with faculty or students by providing this version of the manuscript for personal use.

 

 Once the final version of the manuscript is published, it is the author’s responsibility to add a link to the published article to the publication record. The posted text should not be modified based on the reviewer’s and editor’s comments. Do not replace the text of the posted manuscript. Do not delete the text of the posted manuscript.

 

Revenue Sources

The publication of the journal is financed by the funds of the parent organization, at the expense of the publisher, publication of advertising materials, publication of reprints, article processment charges.

 

CrossMark Policy

CrossMark is a multi-publisher initiative from Crossref, provides a standard way for readers to locate the authoritative version of an article or other published content. By applying the CrossMark logo, journal «Allergology and Immunology in Pediatrics» is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur.

Clicking the CrossMark logo on a document will tell you its current status and may also give you additional publication-record information about the document.

 

Data sharing policy

Authors are encouraged to make the research data that support their publications available but are not required to do so. The decision to publish will not be affected by whether or not authors share their research data.

Definition of research data

This policy applies to the research data that would be required to verify the results of research reported in articles published in the journal «Allergology and Immunology in Pediatrics». Research data include data produced by the authors (“primary data”) and data from other sources that are analysed by authors in their study (“secondary data”). Research data includes any recorded factual material that are used to produce the results in digital and non-digital form. This includes tabular data, code, images, audio, documents, video, maps, raw and/or processed data.

Definition of exceptions

The data that is not a subject to public disclosure may be delivered as follows: deposited in science data repositories with limited access or preliminary anonymised. An author can also publicly deliver metadata only and/or description of the method of access to the data under requests from other scholars.

Data repositories

The preferred mechanism for sharing research data is via data repositories. Please see or https://repositoryfinder.datacite.org/ for help finding research data repositories.

Data citation

The Editorial Board of the Journal   «Allergology and Immunology in Pediatrics» welcomes access to data under Creative Commons Licenses. Editorial Board of the Journal   «Allergology and Immunology in Pediatrics» does not insist on the obligatory use of Creative Commons in case when the data is deposited in the repositories of the third party. The Publisher of the Journal   «Allergology and Immunology in Pediatrics» does not assert any copyrights for the data submitted by the author together with the article.  

Questions regarding the observation of that policy shall be sent to the executive secretary of the Journal   «Allergology and Immunology in Pediatrics».

 

Principles on informed consent

The journal «Allergology and Immunology in Paediatrics» relies on the principles of the World Medical Association's (WMA) policy statement - the Declaration of Helsinki - a statement of Ethical Principles for Medical Research Involving Human Subjects) and endeavours to ensure compliance with ethical and data collection standards for research involving human subjects. Before beginning research, the researchers should familiarise themselves with the principles of the Helsinki Declaration on informed consent and carry out the research in strict accordance with those principles as set forth below (Articles 25-32 of the Helsinki Declaration are given):

  1. Participation by individuals capable of giving informed consent as subjects in medical research must be voluntary. Although, it may be appropriate to consult family members or community leaders, no individual capable of giving informed consent may be enrolled in a research study unless he/she freely agrees.

26 In medical research involving human subjects capable of giving informed consent, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study and the discomfort it may entail, post-study provisions and any other relevant aspects of the study.  The potential subject must be informed of his right to refuse to participate in the study or to withdraw his consent to participate at any time without reprisal. Special attention should be given to the specific information needs of individual potential subjects as well as the methods used to deliver the information.

After ensuring that the potential subject has understood the information, the physician or another appropriately qualified individual must then seek the potential subject's freely-given informed consent, preferably in writing.  If the consent cannot be expressed in writing, verbal consent must be formally documented and witnessed.

All medical subjects should be given the option of being informed about the general outcome and results of the study.

  1. When seeking informed consent for participation in a research study, the physician must be particularly cautious when the potential subject is in a dependent relationship with the physician or may consent under duress. In such situations, the informed consent must be sought by an appropriately qualified individual who is completely independent of this relationship.
  2. For a potential research subject who is incapable of giving informed consent, the physician must seek informed consent from his legally authorised representative. These individuals must not be included in a research study that has no likelihood of benefit for them unless it is intended to promote the health of the group represented by the potential subject, the research cannot instead be performed with persons capable of providing informed consent, and the research entails minimal risk and burden.

 When a potential research subject who is deemed incapable of giving informed consent is able to give assent to decisions about participation in research, the physician must seek that assent in addition to the consent of the legally authorised representative. The potential subject's dissent should be respected.

  1. Research involving subjects who are physically or mentally incapable of giving consent, for example, unconscious patients, may be done only if the physical or mental condition that prevents giving informed consent is a necessary characteristic of the research group. In such circumstances the physician must seek informed consent from the legally authorised representative. If no such representative is available and if the research cannot be delayed, the study may proceed without informed consent provided that the specific reasons for involving subjects with a condition that renders them unable to give informed consent have been stated in the research protocol and the study has been approved by a research ethics committee. Consent to remain in the research must be obtained as soon as possible from the subject or a legally authorised representative.
  2. The physician must fully inform the patient which aspects of their care are related to the research. The refusal of a patient to participate in a study or the patient's decision to withdraw from the study should never adversely affect the patient-physician relationship.
  3. For medical research using identifiable human material or data, such as research on material or data contained in biobanks or similar repositories, physicians must seek informed consent for its collection, storage and/or reuse. There may be exceptions where consent would be impossible or impractical to obtain for such research. In such situations, the research may be done only after consideration and approval of a research ethics committee.

 

Advertising in a medical journal

The text is based on Recommendations on Publication Ethics Policies for Medical Journals WAME.

The Editorial Board of Allergology and Immunology in Pediatrics receives revenue from advertising or reprints, which presents a potential conflict of interest.

The editorial board confirms that

  • PDF is an electronic version of a specialized printed periodical journal for healthcare and pharmaceutical professionals. By viewing the PDF, the user confirms that he/she is a medical or pharmaceutical professional.
  • The decision to publish an article is independent of the cost of advertising or printing a reprint.
  • The functions of the editor and advertising manager are separate in the Journal.
  • Advertisers and sponsors have no control over the editor's decisions, regardless of advertising terms or other agreements.
  • Reprints are published only as originally published in the journal (including subsequent corrections), so there should be no additions or changes.
  • The content of special supplementary issues (if any) is regulated only by the editor's decisions; the content of such an issue is not influenced by sponsors or advertisers.
  • Limitations on the volume of advertising materials in the journal are described and included in the journal's policy. Articles in supplemental issues undergo peer review similar to the journal's standard procedure.
  • The official advertising policy of the journal Allergology and Immunology in Pediatrics is available to all participants in the editorial and publishing process.

 

Design of the advertising product.

Technical requirements for the design of the advertising product are available at the links.

 

All advertisements must uniquely identify the advertiser and the product or service offered. Drug advertisements must include the full name of each active ingredient.

Commercial advertisements should not be placed next to any editorial or article that discusses the product being advertised, nor should they reference the issue of the Journal in which they are placed.

Advertising content should be distinguished from editorial and other material so that the difference between the two is obvious.

Advertisements must not deceive or mislead. Advertisements must not exaggerate the real characteristics of the advertised product. Advertisements must not contain offensive considerations of a religious, racial, sectarian nature.

The advertised products must be oriented toward the practice of medicine, medical education, or the delivery of health care.

  • The Journal shall have the right to refuse to publish any advertisement for any reason. The decision to publish an advertisement should be made only with the participation of the editor and the editorial board of the journal.

 

Access Policy

The Open Access Policy is in line with the definition of the Budapest Open Access Initiative (BOAI) and allows articles to be publicly available on the internet. This means that all users can read, download, copy, distribute, print, search, or link to full texts of articles. They can also scan articles for indexing, transfer them as data for software, or use them for other legitimate purposes without financial, legal, or technical barriers. However, there are some exceptions to this policy. These exceptions include any activities that are inseparable from accessing the internet itself.

For more information about these exceptions, please refer to the Budapest Declaration. (https://www.budapestopenaccessinitiative.org/)

 

Business model of activity

Financially supported by the Association of Pediatric Allergologists and Immunologists of Russia, we charge a fee for reprints and the placement of advertising modules. However, there is no fee for authors, and access to the content is free of charge.



Association of Paediatric Allergists and Immunologists of Russia (APAIR),
All-Russian Public Organization

Executive Director: Yuriy S. Smolkin
Publisher Address: 6 Ostrovityanova Str., Moscow, 117513, Russia
Phone: +7(495) 2257107
Fax: 8(495) 225-7107
E-mail: adair@adair.ru

Processing of personal data
supported by NEICON (Elpub lab)